Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Double- triple bagger from this level
Tomorrow/ next day could fill that gap to .09
Level 2 super thin this could explode!
Moving nicely ask getting hit ...volume coming in, must hitting some scanners
Hourly MACD curling up
Hourly chart setting up for a pop
Got some more right here looking for a push
What the heck was that .025 sell?
Leg up
Next let up starting
It shakes hard, don’t panic , grab dips
Thin Level 2
Hello .06s
.07s looks doable today/ tomorrow
Mean shakeout....reminds me of TLSS when it first got going
Could be in for a nice ride here
“For the year ended December 31, 2019, our gross profit was $2,603,362, or 8.3% of revenue, as compared to $834,735, or 6.1% of revenue, for the year ended December 31, 2018, an increase of $1,768,627. The increase in gross profit primarily resulted from the acquisition of Prime EFS on June 18, 2018.”
And First quarter 2020 revenue is up 49%
https://www.bloomberg.com/press-releases/2020-04-28/transportation-and-logistics-systems-inc-announces-preliminary-first-quarter-2020-revenues-increased-49-over-same-period-in
“WEST PALM BEACH, FLORIDA, April 28, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE
-- Transportation and Logistics Systems, Inc. (OTC:TLSS), (“TLSS", or the
“Company”), a leading eCommerce fulfillment service provider, announced today
that its preliminary first quarter revenues for the period ended March 31,
2020 increased by approximately $2.8 million, or 49%, to approximately $8.6
million, compared to $5.8 million in revenue reported in the same period in
2019. The Company advises that these numbers have not yet been reviewed by
its auditors due to the pandemic and may be subject to adjustment.”
Weekly MACD just crossed
Looking good for next week
Quiet accumulation happening
Next week should be good just based on chart technicals....then when we get news will send this
Strong hands holding this
News Monday morning would be amazing either way chart looks primed to move north next week
Up 2.5% on the day and above average volume for a dark stop sign stock...something is in the works
Reversal underway
Anyone have the current share structure?
Thanks... this is looking like the next monster
Grabbed a starter....anyone got the lowdown on this play ?
Holding this level nicely for the next leg up
Things are moving along now that Hyperion is out...I’m thinking we’re weeks not months out
Weekly chart could start moving north anytime now and if we get a PR this will move fast
Weekly chart technicals says this is ready to run back up soon...maybe next week and if we get a PR we’ll be back in action
.30 close ?
Dollars next week??
Almost a cool .25 already
Bigly Gap-Up coming
Next 4 hr candle going to
Be cray cray IMO
Aaaaaand BOOOOM
Soon will be making another run
$TLSS Boat
Come aboard we’re expecting you
$TLSS Boat
Not too late to get in I meant
LOL
Gap ups all day
Not too early to get in....look at weekly chart lots of gaps to fill upwards
PLANO, TX / ACCESSWIRE / April 16, 2020 / Enzolytics - (OTC PINK:ENZC) is pleased to update shareholders on the current corporate initiatives. The company has retained SEC counsel for the purpose of updating all corporate information, financials and to bring the company current from a public company perspective and allow the achievement of the company objectives.
The immediate goals include:
- Regain Current Status with OTC Markets
- Open operation in the Dallas, Tx area where the company has relocated
- Identify a CMO, Contract Manufacturing Organization , to produce the validation batch for Immunotech Laboratories BG-Europe.
- Assist Immunotech Laboratories BG-Europe in the registration of ImmunH as an Immunomodulator for HIV treatment.
- Further our development in North America of our Flagship HIV immune treatment compound IPF
As it relates to the CMO and production of the initial validation batch of our lead product ITV-1, which will be marketed in Europe as ImmunH through our partner, Immunotech Laboratories BG-Europe. This is for the treatment of HIV/Aids, and the validation batch production is for the purpose of Phase IV, as required by the regulatory agencies as part of the mass use permitting process. Upon a successful validation batch, the intention is for full commercialization in Eastern Europe initially, then expansion to additional markets. Enzolytics owns 49% of Immunotech Laboratories BG-Europe.
The company has made updates to its corporate website, insert-text-here, and will continue to do so to provide further information to our shareholders.
About ENZOLYTICS ;
Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins for the treatment of HIV/AIDS. Enzolytics is committed to the betterment of health for all mankind and exploring/developing additional applications of its novel immunotherapy compounds to that end.
Enzolytics flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction (IPF), which studies have shown is effective in the treatment of HIV/AIDS. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system.
Clear 08-09 with power and we’re off to .20
Looks like she wants another leg up
If we can push thru 07–08’s this will see a quarter
Closing nicely tomorrow should be fun